Fast Five Quiz: HIV Pre-exposure Prophylaxis: Selecting Appropriate Candidates

Jason F. Okulicz, MD

Disclosures

January 20, 2021

A recent US Preventive Services Task Force Recommendation Statement indicated that PrEP should be considered for individuals with a diagnosis of a sexually transmitted infection in the past 6 months.

PrEP should be considered for intravenous drug users who share drug injection equipment and are at risk for sexual HIV acquisition.

To reduce the risk for transmission of drug resistance, PrEP should not be considered for individuals with signs or symptoms of acute viral infection unless HIV-uninfected status is confirmed by HIV RNA testing or a repeat antibody test is performed after the viral syndrome resolves.

For individuals who have had condomless sex in the past 72 hours with a person of unknown HIV status, consider postexposure prophylaxis (PEP) rather than PrEP.

For additional information, refer to the US Preventive Services Task Force Recommendation Statement.

Learn more about the criteria for PreP.

Comments

3090D553-9492-4563-8681-AD288FA52ACE
Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.
Post as:

processing....